New polymyxin analogs for the treatment of multidrug-resistant gram-negative nosocomial pathogens

被引：0

作者：

Magee, Thomas ^{[1
]}

Brown, Matthew ^{[1
]}

Starr, Jeremy ^{[1
]}

Miller, Alita ^{[1
]}

Leach, Karen ^{[1
]}

Tomaras, Andrew ^{[1
]}

Dib-Hajj, Fadia ^{[1
]}

Huband, Michael ^{[1
]}

McCurdy, Sandra ^{[1
]}

Irvine, Rebecca ^{[1
]}

Seibel, Scott ^{[1
]}

Luke, David ^{[1
]}

Ackley, David ^{[1
]}

Butler, Andrew ^{[1
]}

Aubrecht, Jiri ^{[1
]}

Granskog, Karl ^{[1
]}

Hardink, Joel ^{[1
]}

Mckim, James ^{[1
]}

Thuy-Trinh Nguyen ^{[1
]}

O'Donnell, John ^{[1
]}

Shen, Yue ^{[1
]}

Wilga, Paul ^{[1
]}

Xu, Jinfeng ^{[2
]}

Zhang, Li ^{[3
]}

Stepan, Antonia ^{[1
]}

Chen, Jinshan ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

[2] Chinese Peptide Co, Hangzhou, Zhejiang, Peoples R China

[3] Wuxi AppTech, Shanghai, Peoples R China

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

397-MEDI

引用

页数：1

共 50 条

[31] The Dilemma of Multidrug-Resistant Gram-Negative Bacteria
Engel, Lee S.
[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03): : 232 - 237
[32] Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens
Kadouri, Daniel E.
To, Kevin
Shanks, Robert M. Q.
Doi, Yohei
[J]. PLOS ONE, 2013, 8 (05):
[33] Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens
Abdul-Mutakabbir, Jacinda C.
Alosaimy, Sara
Morrisette, Taylor
Kebriaei, Razieh
Rybak, Michael J.
[J]. PHARMACOTHERAPY, 2020, 40 (12): : 1228 - 1247
[34] Antibiotic synergy testing for multidrug-resistant Gram-negative pathogens in a Greek ICU
E Douka
E Perivoliot
E Kraniotaki
M Nepka
C Routsi
K Fountoulis
A Skoutelis
S Zakynthinos
[J]. Critical Care, 19 (Suppl 1):
[35] Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B A Retrospective study
Liu, Dongsheng
Niu, Jianxing
Chen, Guoqiang
Xu, Long
[J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 7653 - 7666
[36] Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria
Teng, Christine B.
Koh, Peai T.
Lye, David C. B.
Ang, Brenda S.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (01) : 80 - 82
[37] Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B
Pereira, Graziella H.
Muller, Patricia R.
Levin, Anna S.
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (02) : 235 - 240
[38] Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
Jie, Augustine Koh Jing
Hussein, Maytham
Rao, Gauri G. G.
Li, Jian
Velkov, Tony
[J]. PATHOGENS, 2022, 11 (12):
[39] The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms
Noval, Mandee
Banoub, Mary
Claeys, Kimberly C.
Heil, Emily
[J]. CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (01)
[40] The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms
Mandee Noval
Mary Banoub
Kimberly C. Claeys
Emily Heil
[J]. Current Infectious Disease Reports, 2020, 22

← 1 2 3 4 5 →